1.43
-0.07 (-4.67%)
| Previous Close | 1.50 |
| Open | 1.46 |
| Volume | 34,320 |
| Avg. Volume (3M) | 211,819 |
| Market Cap | 9,700,462 |
| Price / Earnings (TTM) | 11.92 |
| Price / Sales | 1.44 |
| Price / Book | 2.00 |
| 52 Weeks Range |
| Operating Margin (TTM) | -372.76% |
| Diluted EPS (TTM) | 0.120 |
| Quarterly Revenue Growth (YOY) | -20.50% |
| Total Debt/Equity (MRQ) | 14.89% |
| Current Ratio (MRQ) | 0.920 |
| Operating Cash Flow (TTM) | -10.10 M |
| Levered Free Cash Flow (TTM) | -6.07 M |
| Return on Assets (TTM) | -76.78% |
| Return on Equity (TTM) | -291.77% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Intelligent Bio Solutions Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 0.0 |
| Average | 0.25 |
|
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment). |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 1.40% |
| % Held by Institutions | 1.27% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |